NR calculated 35 million shares traded since April 1st. With 10 million between the lawyers and Aruda hopefully that $0 cost basis supply is getting close to being exhausted. That would only leave Aspire who will have a much higher cost basis.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links